Summary of Consolidated Financial Results for the Three Months Ended August 31, 2026 (Under Japanese GAAP) [English]

Daito Pharmaceutical Co. Ltd. published this content on October 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 14, 2026 at 07:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]